Heartbeat Medical, a German digital health startup, raised €5Mm in Series A funding.
The round was led by new investor btov Partners and existing investor HV Holtzbrinck Ventures. In addition, High-Tech Gründerfonds (HTGF) is increasing its holdings.
The company intends to use the funds for organizational development and expansion of capabilities of skills in the field of data analysis.
Founded in 2014, heartbeat medical is a leader in the collection and analysis of Patient-Reported Outcome Data (PROMs) and their linkage to clinical observations and embedding in treatments. The 40-strong team works from Berlin, Cologne and London on product development and support for over 200 hospital departments, registries and research projects. The Patient Reported Outcomes data are collected directly from patients in the form of standardised questionnaires and offer insights into the individually perceived treatment effects. Automatically linked to clinical data, a data-based foundation for decisions on medical and economic issues is thus created. Its medical platform, which is approved as a medical device, is already being used in a variety of ways for therapies and research as well as for the evaluation of medical components in regulatory procedures.